Aeglea BioTherapeutics Inc. (AGLE) Stock Price

9.02 ▼ -0.28 (-3.01%)
Open: 9.18 Vol: 100.26K Day's range: 9.02 - 9.275 Oct 22, 15:49 EDT
IEX Real-Time Price
Free Stock Screener
Loading chart ...
AGLE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 9.13▼ 9.14▼ 9.14▼ 9.56▼ 9.35▼
MA10 9.30▼ 9.45▼ 9.46▼ 9.37▼ 9.44▼
MA20 9.62▼ 9.57▼ 9.51▼ 9.47▼ 9.53▼
MA50 9.60▼ 9.53▼ 9.44▼ 9.38▼ 8.36▲
MA100 9.51▼ 9.55▼ 9.55▼ 9.59▼ 6.69▲
MA200 9.64▼ 9.38▼ 9.14▼ 8.95▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.085▼ -0.090▼ -0.088▼ -0.021▼ N/A    
RSI 27.615▼ 34.038▼ 35.530▼ 45.675▼ N/A    
STOCH 2.392▼ 2.337▼ 2.337▼ 57.904     40.836    
WILL %R -100.000▼ -100.000▼ -100.000▼ -77.368▼ -68.810    
CCI -79.697     -101.380▼ -103.168▼ -98.374     -37.612    
Latest Filters Detected On AGLE
MA $AGLE Price Crossed Below MA(26) Set Alert
▼ MACD $AGLE MACD(12,26,9) Crossed Below Signal Line Set Alert
Aeglea BioTherapeutics Inc. News
Aeglea Bio's pegzilarginase shows positive effect in Phase 1/2 ARG1-D study
Wednesday, October 17, 2018 07:56 AM
Preliminary results from a Phase 1/2 clinical trial evaluating Aeglea BioTherapeutics' (AGLE-4.2%) lead candidate pegzilarginase in patients with rare inherited disorder called Arginase 1 ...
The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise
Wednesday, October 17, 2018 05:15 AM
Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) will present interim Phase 2 data for Pegzilarginase in treating Arginase deficiency. Auris Medical Holding AG (NASDAQ: EARS) is scheduled to release Phase 1 ...
Aeglea BioTherapeutics (AGLE) Reports New Positive Interim Clinical Data from Ongoing Phase 1/2 Trial of pegzilarginase
Wednesday, October 17, 2018 04:01 AM
Claim your 2-week free trial to StreetInsider Premium here. Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) today announced new positive interim clinical data at the 2018 American Society of Human Genetic...
AGLE historical stock data
date open high low close volume
22/10/18 9.18 9.275 9.02 9.02 100,260
19/10/18 9.88 10.28 9.16 9.30 253,540
18/10/18 9.52 9.99 9.31 9.90 189,528
17/10/18 9.75 10.10 9.05 9.57 281,917
16/10/18 9.48 10.11 9.48 10.02 229,696
15/10/18 9.06 9.63 8.94 9.41 207,304
12/10/18 9.31 9.39 8.77 9.08 211,674
11/10/18 8.81 9.47 8.59 9.07 180,198
10/10/18 9.50 9.55 8.83 8.84 175,621
09/10/18 9.63 9.93 9.3865 9.51 124,653
Quote Details
Bid:0.00
Ask:0.00
52wk Low:3.75
52wk High:12.00
Vol:100.26K
Avg Vol(3m):4.4M
1Y Chng:+93.15%
1M Chng:+4.64%
Add to Watch List
More Information
Index NASDAQ Composite
Market Cap. 218.61M